Literature DB >> 9445032

Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins.

B Sherry1, J Torres, M A Blum.   

Abstract

Reovirus-induced acute myocarditis in mice serves as a model to investigate non-immune-mediated mechanisms of viral myocarditis. We have used primary cardiac myocyte cultures infected with a large panel of myocarditic and nonmyocarditic reassortant reoviruses to identify determinants of viral myocarditic potential. Here, we report that while both myocarditic and nonmyocarditic reoviruses kill cardiac myocytes, viral myocarditic potential correlates with viral spread through cardiac myocyte cultures and with cumulative cell death. To address the role of secreted interferon (IFN), we added anti-IFN-alpha/beta antibody to infected cardiac myocyte cultures. Antibody benefited nonmyocarditic more than myocarditic virus spread (P < 0.001), and this benefit was associated with the reovirus M1 and L2 genes. There was no benefit for a differentiated skeletal muscle cell line culture (C2C12 cells), suggesting cell type specificity. IFN-beta induction in reovirus-infected cardiac myocyte cultures correlated with viral myocarditic potential (P = 0.006) and was associated with the reovirus M1, S2, and L2 genes. Sensitivity to the antiviral effects of IFN-alpha/beta added to cardiac myocyte cultures also correlated with viral myocarditic potential (P = 0.004) and was associated with the same reovirus genes. Several reoviruses induced IFN-beta levels discordant with their myocarditic phenotypes, and for those tested, sensitivity to IFN-alpha/beta compensated for the anomalous induction levels. Thus, the combination of induction of and sensitivity to IFN-alpha/beta is a determinant of reovirus myocarditic potential. Finally, a nonmyocarditic reovirus induced cardiac lesions in mice depleted of IFN-alpha/beta, demonstrating that IFN-alpha/beta is a determinant of reovirus-induced myocarditis. This provides the first identification of reovirus genes associated with IFN induction and sensitivity and provides the first evidence that IFN-beta can be a determinant of viral myocarditis and reovirus disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445032      PMCID: PMC124610     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Mechanism of interferon action. Activation of the human P1/eIF-2 alpha protein kinase by individual reovirus s-class mRNAs: s1 mRNA is a potent activator relative to s4 mRNA.

Authors:  J R Bischoff; C E Samuel
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

2.  The M1 gene is associated with differences in the temperature optimum of the transcriptase activity in reovirus core particles.

Authors:  P Yin; M Cheang; K M Coombs
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

3.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

4.  Multiple viral core proteins are determinants of reovirus-induced acute myocarditis.

Authors:  B Sherry; M A Blum
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection.

Authors:  S De Castro; G d'Amati; P Gallo; D Cartoni; P Santopadre; V Vullo; A Cirelli; G Migliau
Journal:  J Am Coll Cardiol       Date:  1994-10       Impact factor: 24.094

6.  Requirement of MIP-1 alpha for an inflammatory response to viral infection.

Authors:  D N Cook; M A Beck; T M Coffman; S L Kirby; J F Sheridan; I B Pragnell; O Smithies
Journal:  Science       Date:  1995-09-15       Impact factor: 47.728

7.  Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.

Authors:  M A Meraz; J M White; K C Sheehan; E A Bach; S J Rodig; A S Dighe; D H Kaplan; J K Riley; A C Greenlund; D Campbell; K Carver-Moore; R N DuBois; R Clark; M Aguet; R D Schreiber
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

8.  Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.

Authors:  J E Durbin; R Hackenmiller; M C Simon; D E Levy
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

9.  Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice.

Authors:  U Steinhoff; U Müller; A Schertler; H Hengartner; M Aguet; R M Zinkernagel
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene.

Authors:  E Beattie; K L Denzler; J Tartaglia; M E Perkus; E Paoletti; B L Jacobs
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more
  52 in total

Review 1.  Reovirus receptors and pathogenesis.

Authors:  J Craig Forrest; Terence S Dermody
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

2.  Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system.

Authors:  Lauren N Luethy; Andrea K Erickson; Palmy R Jesudhasan; Mine Ikizler; Terence S Dermody; Julie K Pfeiffer
Journal:  Virology       Date:  2015-10-16       Impact factor: 3.616

3.  Reovirus induces and benefits from an integrated cellular stress response.

Authors:  Jennifer A Smith; Stephen C Schmechel; Arvind Raghavan; Michelle Abelson; Cavan Reilly; Michael G Katze; Randal J Kaufman; Paul R Bohjanen; Leslie A Schiff
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Silencing and complementation of reovirus core protein mu2: functional correlations with mu2-microtubule association and differences between virus- and plasmid-derived mu2.

Authors:  John Carvalho; Michelle M Arnold; Max L Nibert
Journal:  Virology       Date:  2007-04-23       Impact factor: 3.616

5.  An ITAM in a nonenveloped virus regulates activation of NF-κB, induction of beta interferon, and viral spread.

Authors:  Rachael E Stebbing; Susan C Irvin; Efraín E Rivera-Serrano; Karl W Boehme; Mine Ikizler; Jeffrey A Yoder; Terence S Dermody; Barbara Sherry
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

6.  NF-κB activation is cell type-specific in the heart.

Authors:  Efraín E Rivera-Serrano; Barbara Sherry
Journal:  Virology       Date:  2016-12-30       Impact factor: 3.616

7.  Identification of functional domains in reovirus replication proteins muNS and mu2.

Authors:  Takeshi Kobayashi; Laura S Ooms; James D Chappell; Terence S Dermody
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease.

Authors:  Sean M O'Donnell; Mark W Hansberger; Jodi L Connolly; James D Chappell; Melissa J Watson; Janene M Pierce; J Denise Wetzel; Wei Han; Erik S Barton; J Craig Forrest; Tibor Valyi-Nagy; Fiona E Yull; Timothy S Blackwell; Jeffrey N Rottman; Barbara Sherry; Terence S Dermody
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

9.  Bid regulates the pathogenesis of neurotropic reovirus.

Authors:  Pranav Danthi; Andrea J Pruijssers; Angela K Berger; Geoffrey H Holm; Sandra S Zinkel; Terence S Dermody
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

Review 10.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.